$96.42
+8.08 (+9.15%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+192.71%
1Y
+556.81%
YTD
+215.30%
Open$96.85
Previous Close$88.34
Day High$98.18
Day Low$95.00
52W High$90.99
52W Low$14.00
Volume—
Avg Volume1.38M
Market Cap7.67B
P/E Ratio—
EPS$-2.50
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$33.24
Above
SMA 200
$22.06
Above
RSI (14)
64.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
-18.1% upside
Current
$96.42
$96.42
Target
$78.92
$78.92
$58.92
$78.92 avg
$128.60
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 469.29M | 433.92M | 481.69M |
| Net Income | -23,759,261 | -24,167,490 | -23,392,315 |
| Profit Margin | -5.1% | -5.6% | -4.9% |
| EBITDA | -33,340,073 | -28,197,061 | -36,465,134 |
| Free Cash Flow | -26,670,161 | -19,444,681 | -29,871,207 |
| Rev Growth | +18.1% | +19.4% | +22.5% |
| Debt/Equity | 0.73 | 0.87 | 0.77 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |